Phase I Study of OriC902 in Treatment of Advanced HCC
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to HCC
Related studies linked through entity extraction aliases.
A Phase II/III Trial Comparing Transarterial Tirapazamine Embolization (TATE) With cTACE for Intermediate-stage Liver Cancer.
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein Thrombosis
- Status
- RECRUITING
- Phase
- PHASE2
Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of IMM2510 + IMM27M Combination Therapy in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Effect of the HCC Liver-Link Intervention
- Status
- RECRUITING
- Phase
- NA
HOPE Against Cancer Recurrence in HCC
- Status
- RECRUITING
- Phase
- PHASE4
A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate of PM8002 Combined With PM1009 in Patients With First-line HCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
ICIs With and Without MWA in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A
CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical Resection
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of Risk of hEpatocellular Carcinoma
- Status
- RECRUITING
- Phase
- NA
Precision Treatment of Unresectable HCC Guided by Multi-omics Deep Learning Models
- Status
- RECRUITING
- Phase
- PHASE1
Intra-Tumoral Vascular Growth Patterns is a Robust Indicator of Adjuvant Therapy Following Liver Resection in HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
SBRT in HCC With Oligoprogression on First-line Immunotherapy
- Status
- RECRUITING
- Phase
- NA
Neoadjuvant Therapy in Patients With Resectable HCC Screened by a Multimodal Deep Learning Model
- Status
- RECRUITING
- Phase
- PHASE2
Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure
- Status
- RECRUITING
- Phase
- PHASE2
Triple vs. Dual Adjuvant Therapy Following Liver Resection for HCC.
- Status
- RECRUITING
- Phase
- PHASE4